AI
PFE icon

Arvest Investments’s Pfizer PFE Stock Holding History

Arvest Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756K Sell
31,383
-717
-2% -$18.8K 0.09% 115
2026
Q1 		$901K Sell
32,100
-649
-2% -$17.3K 0.12% 108
2025
Q4 		$815K Sell
32,749
-2,876
-8% -$72.5K 0.11% 115
2025
Q3 		$908K Sell
35,625
-364
-1% -$8.98K 0.13% 119
2025
Q2 		$872K Sell
35,989
-12,776
-26% -$298K 0.13% 120
2025
Q1 		$1.24M Sell
48,765
-43,356
-47% -$1.13M 0.19% 107
2024
Q4 		$2.44M Sell
92,121
-7,046
-7% -$191K 0.39% 52
2024
Q3 		$2.87M Buy
99,167
+3,917
+4% +$114K 0.43% 50
2024
Q2 		$2.67M Sell
95,250
-2,406
-2% -$66.2K 0.43% 49
2024
Q1 		$2.71M Sell
97,656
-10,235
-9% -$284K 0.43% 47
2023
Q4 		$3.11M Buy
+107,891
New +$3.26M 0.5% 42

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arvest Investments's PFE Position: Q2 2026 in Review

Arvest Investments reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $18.8K and leaving 31,383 shares worth $756K. The position accounts for 0.09% of the portfolio, ranked #115.

Arvest Investments first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.11M in Q4 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Arvest Investments held 31,383 shares of Pfizer worth $756K as of Q2 2026.
  • Arvest Investments sold 717 Pfizer shares in Q2 2026, an estimated $18.8K.
  • Pfizer made up 0.09% of Arvest Investments's portfolio in Q2 2026, its #115 holding.
  • Arvest Investments first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Arvest Investments's Pfizer position peaked at $3.11M in Q4 2023.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Arvest Investments's 13F filing for Q2 2026, filed 17 Jul 2026.